James Demetroulakos, MD
Otolaryngology · Danvers, MANPI 1326011180
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (50.6%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Inspire Medical Systems, Inc. accounts for 91.8% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2022 at $1,661 and has fallen 84.0% since, to $266 in 2025.
Across 30 payments — averaging $113.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$3K
- Medtronic$150
- Sanofi$77
- Regeneron Healthcare Solutions, Inc.$29
- Stryker$21
Across 6 payments — averaging $4166.67 each. An ownership or investment interest held by the physician or an immediate family member.
- Agile Devices, Inc.$25K
What the payments were for
- Consulting fees$1504%
- Travel & lodging$1,52445%
- Food & beverage$1,71651%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 25 | $3,113 |
| Medtronic | 1 | $150 |
| Sanofi | 2 | $77 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| Stryker | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,391 in reported general payments places this provider in the 80th percentile of 298 otolaryngology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 13 | $47,393 |
| Azelastine Hcl | 505 | $10,453 |
| Famotidine | 272 | $3,426 |
| Ipratropium Bromide | 98 | $2,148 |
| Dexamethasone | 18 | $1,867 |
| Ofloxacin | 25 | $1,640 |
| Fluticasone Propionate | 79 | $1,310 |
| Fluocinolone Acetonide Oil | 35 | $1,201 |
| Hydrocortisone-Acetic AcidHydrocortisone/Acetic Acid | 14 | $1,081 |
| Cephalexin | 49 | $296 |
| Methylprednisolone | 29 | $287 |
| Triamcinolone Acetonide | 12 | $221 |
| ValacyclovirValacyclovir Hcl | 14 | $161 |
| Doxycycline Monohydrate | 15 | $131 |
| Montelukast Sodium | 11 | $129 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Danvers
- Allen FengDanvers$4K
- Ayesha KhalidConcord$511K
- Dennis PoeBoston$264K
- Peter WeberBoston$157K
- Kevin EmerickBoston$89K
- Benjamin BleierBoston$77K
- Gregory RandolphBoston$56K
- Daniel LeeBoston$52K
- Pratik PradhanBrockton$51K
- Marika RussellBoston$50K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.